EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Amphastar Pharmaceuticals's enterprise value is $2,258.7 Mil.
Amphastar Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $644.4 Mil. Therefore, Amphastar Pharmaceuticals's EV-to-Revenue for today is 3.51.
The historical rank and industry rank for Amphastar Pharmaceuticals's EV-to-Revenue or its related term are showing as below:
AMPH'
s EV-to-Revenue Range Over the Past 10 Years
Min: 1.63 Med: 3.02 Max: 6.84
Current: 3.51
During the past 13 years, the highest EV-to-Revenue of Amphastar Pharmaceuticals was 6.84. The lowest was 1.63. And the median was 3.02.
AMPH's EV-to-Revenue is ranked worse than 68.59% of 1025
companies
in the Drug Manufacturers industry
Industry Median: 2.33
vs AMPH: 3.51
As of today (2024-04-19), Amphastar Pharmaceuticals's stock price is $39.425.
Amphastar Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $12.15. Therefore, Amphastar Pharmaceuticals's PS Ratio for today is 3.25.
Amphastar Pharmaceuticals EV-to-Revenue Historical Data
The historical data trend for Amphastar Pharmaceuticals's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Amphastar Pharmaceuticals Annual Data
Trend
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Dec23
EV-to-Revenue
2.87
2.75
2.47
2.56
5.18
Amphastar Pharmaceuticals Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
EV-to-Revenue
2.56
3.31
5.86
4.28
5.18
Competitive Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Amphastar Pharmaceuticals's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Amphastar Pharmaceuticals EV-to-Revenue Distribution
For the Drug Manufacturers industry and Healthcare sector, Amphastar Pharmaceuticals's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Amphastar Pharmaceuticals's EV-to-Revenue falls into.
Amphastar Pharmaceuticals's current Enterprise Value is $2,258.7 Mil.
Amphastar Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $644.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amphastar Pharmaceuticals's share price for today is $39.425.
Amphastar Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $12.15.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Amphastar Pharmaceuticals EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Amphastar Pharmaceuticals's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Amphastar Pharmaceuticals (Amphastar Pharmaceuticals) Business Description
Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AMPH has been successfully added to your 